(-0.07%) 5 474.50 points
(-0.11%) 38 776 points
(-0.04%) 19 913 points
(0.17%) $80.47
(1.26%) $2.82
(0.24%) $2 334.60
(-0.19%) $29.34
(-0.23%) $968.70
(0.00%) $0.932
(-0.19%) $10.63
(0.06%) $0.788
(-1.87%) $86.79
Live Chart Being Loaded With Signals
Cleveland BioLabs, Inc. operates as a biopharmaceutical company, which engages in the research and development of drugs. The company is headquartered in Buffalo, New York and currently employs 15 full-time employees...
Stats | |
---|---|
Šios dienos apimtis | 116 255 |
Vidutinė apimtis | 156 953 |
Rinkos kapitalizacija | 226.39M |
EPS | $-0.0426 ( Q2 | 2021-08-16 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
0 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.436 (13.75%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2021-07-27 | Selsky Clifford | Buy | 101 579 | Common Stock, par value $0.005 per share |
2021-07-27 | Aronstam Peter | Buy | 141 370 | Common Stock, par value $0.005 per share |
2021-07-27 | Selsky Clifford | Buy | 0 | |
2021-07-27 | Aronstam Peter | Buy | 0 | |
2021-07-27 | Barbarick Steve K | Buy | 0 |
INSIDER POWER |
---|
0.00 |
Last 91 transactions |
Buy: 2 702 906 | Sell: 404 086 |
Tūris Koreliacija
Cleveland Biolabs Inc Koreliacija
10 Labiausiai neigiamai susiję koreliacijos | |
---|---|
MSAC | -0.926 |
LGACU | -0.906 |
SCOB | -0.901 |
BCOR | -0.883 |
ITQ | -0.877 |
FTIV | -0.833 |
SCOBU | -0.819 |
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Cleveland Biolabs Inc Koreliacija - Valiuta/Žaliavos
Cleveland Biolabs Inc Finansinės ataskaitos
Annual | 2020 |
Pajamos: | $262 942 |
Bruto pelnas: | $262.94 (0.10 %) |
EPS: | $-0.190 |
FY | 2020 |
Pajamos: | $262 942 |
Bruto pelnas: | $262.94 (0.10 %) |
EPS: | $-0.190 |
FY | 2019 |
Pajamos: | $1.11M |
Bruto pelnas: | $0.00 (0.00 %) |
EPS: | $-0.230 |
FY | 2018 |
Pajamos: | $1.14M |
Bruto pelnas: | $0.00 (0.00 %) |
EPS: | $-0.320 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Cleveland Biolabs Inc
Cleveland BioLabs, Inc. operates as a biopharmaceutical company, which engages in the research and development of drugs. The company is headquartered in Buffalo, New York and currently employs 15 full-time employees. The firm is engaged in developing approaches to activate the immune system and address serious medical needs. Its platform of Toll-like immune receptor activators has applications in mitigation of radiation injury and immuno-oncology. Its advanced product candidate is Entolimod, an immuno-stimulatory agent, which it is developing as a radiation countermeasure and an immunotherapy for oncology and other indications. Its other products include CBLB612, Mobilan and CBL0137. CBLB612 is a compound based upon a natural activator of another tissue-specific component of the innate immune system, the toll-like receptor 2 (TLR2)/ toll-like receptor 6 (TLR6) heterodimeric receptor. Mobilan is a recombinant non-replicating adenovirus that directs expression of TLR5 and its agonistic ligand. CBL0137 is a small molecule with a multi-targeted mechanism of action that may be useful for the treatment of various types of cancer.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.